• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form N-PX filed by BlackRock Technology and Private Equity Term Trust

    8/28/25 6:58:08 AM ET
    $BTX
    Get the next $BTX alert in real time by email
    Form N-PX Filer Information UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    FORM N-PX
    ANNUAL REPORT OF PROXY VOTING RECORD
    OMB APPROVAL


    Form N-PX

    OMB Number:  3235-0582


    Estimated average burden hours per response: 20.8

    N-PX: Filer Information

    Filer CIK
    0001836057 
    Filer CCC
    ********  
    Date of Report
    06/30/2025 
    Are you a Registered Management Investment Company or an Institutional Manager?
    Registered Management Investment Company 
    Filer Investment Company Type
    Form N-2 Filer (Closed-End Investment Company) 
    Is this a LIVE or TEST Filing? Radio button checked LIVE Radio button not checked TEST
    Is this an electronic copy of an official filing submitted in paper format? Checkbox not checked

    Submission Contact Information

    Name
     
    Phone Number
     
    E-mail Address
     

    Notification Information

    Notify via Filing Website only?Checkbox not checked

    N-PX: Cover Page

    Name and address of reporting person:

    Name of reporting person (For registered management investment companies, provide exact name of registrant as specified in charter)

    BlackRock Technology & Private Equity Term Trust 

    Street 1

    100 Bellevue Parkway 

    Street 2

     

    City

    Wilmington 

    State/Country

    DELAWARE  

    Zip code and zip code extension or foreign postal code

    19809 

    Telephone number of reporting person, including area code:

    800-882-0052 

    Name and address of agent for service:

    Name of agent for service

    John Perlowski 

    Street 1

    50 Hudson Yards 

    Street 2

     

    City

    New York 

    State/Country

    NEW YORK  

    Zip code and zip code extension or foreign postal code

    10001 

    Reporting Period:Report for the year ended June 30, 2025 
    SEC Investment Company Act or Form 13F File Number:

    811-23625 

    CRD Number (if any):

     

    Other SEC File Number (if any):

     

    Legal Entity Identifier (if any):

     

    Report Type (check only one):

    Registered Management Investment Company.
    Radio button checked Fund Voting Report (Check here if the registered management investment company held one or more securities it was entitled to vote.)
    Radio button not checked Fund Notice Report (Check here if the registered management investment company did not hold any securities it was entitled to vote.)
    Institutional Manager.
    Radio button not checked Institutional Manager Voting Report (Check here if all proxy votes of this reporting manager are reported in this report.)
    Radio button not checked Institutional Manager Notice Report (Check here if no proxy votes are reported in this report and complete the notice report filing explanation section below)
    Radio button not checked Institutional Manager Combination Report (Check here if a portion of the proxy votes for this reporting manager are reported in this report and a portion are reported by other reporting person(s).)
    Do you wish to provide explanatory information pursuant to Special Instruction B.4?: Radio button checked Yes Radio button not checked No
    Additional information:

    BlackRock Technology and Private Equity Term Trust (formerly, BlackRock Innovation and Growth Term Trust). 

    N-PX: Summary - Included Managers

    Number of Included Institutional Managers:

    1 

    Included Institutional Managers:1

    No.:

    19 

    Form 13F File Number [028-]:

    028-04295 

    CRD Number (if any):

    000106614 

    SEC File Number (if any):

    801-47710 

    LEI (if any):

    5493001LN9MRM6A35J74 

    Name:

    BlackRock Advisors, LLC 

    N-PX: Summary - Included Series

    Number of Series:

    0 

    Information about the Series:NONE

    N-PX: Signature Block

    Reporting Person:

    BlackRock Technology & Private Equity Term Trust 

    By (Signature):

    John Perlowski 

    By (Printed Signature):

    John Perlowski 

    By (Title):

    Chief Executive Officer 

    Date:

    08/28/2025 

    Get the next $BTX alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $BTX

    DatePrice TargetRatingAnalyst
    12/29/2021$9.00Overweight
    Cantor Fitzgerald
    10/6/2021$20.00Buy
    Maxim Group
    More analyst ratings

    $BTX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Cantor Fitzgerald initiated coverage on Brooklyn with a new price target

    Cantor Fitzgerald initiated coverage of Brooklyn with a rating of Overweight and set a new price target of $9.00

    12/29/21 7:03:49 AM ET
    $BTX

    Maxim Group initiated coverage on Brooklyn ImmunoTherapeutics with a new price target

    Maxim Group initiated coverage of Brooklyn ImmunoTherapeutics with a rating of Buy and set a new price target of $20.00

    10/6/21 7:53:44 AM ET
    $BTX

    $BTX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    BlackRock Announces Update to BMEZ, BSTZ, and BTX Managed Distribution Plans

    The Board of Trustees (the "Board") of BlackRock Health Sciences Term Trust (BMEZ), BlackRock Science and Technology Term Trust (BSTZ), and BlackRock Technology and Private Equity Term Trust (BTX) (the "Funds") approved updates to each Fund's managed distribution plan that will take effect with the October 2025 distribution. The Funds will change from a floating rate distribution to a level rate distribution at the stated monthly rates provided below. These changes seek to enhance distribution stability while maintaining a competitive distribution rate and offering the potential to grow each Fund's net asset value. Additionally, these changes will help to manage the proportion of public and

    9/10/25 8:06:00 PM ET
    $BMEZ
    $BSTZ
    $BTX
    Trusts Except Educational Religious and Charitable
    Finance

    Certain BlackRock Sector Equity Closed-End Funds Announce Updates to Investment Objectives and Principal Investment Strategies

    The BlackRock Sector Equity Closed End Funds (CEFs) listed below (the "Funds") announced today that each Fund's Board of Trustees (the "Board") has approved the following updates to the Funds' respective investment objectives and principal investment strategies. Effective 11/10/2025, the Funds' investment objectives will be changed as indicated below. Investment objective changes BlackRock Sector CEFs   Ticker   Current Investment Objective   Proposed Investment Objective BlackRock Resources and Commodities Strategy Trust   BCX   The Trust's primary investment objective is to seek high current income and current gains, with a secondary objective

    9/10/25 6:15:00 PM ET
    $BCX
    $BGR
    $BME
    Finance/Investors Services
    Finance
    Trusts Except Educational Religious and Charitable
    Finance Companies

    Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

    Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below. Municipal Funds: Declaration- 9/2/2025 Ex-Date- 9/15/2025 Record- 9/15/2025 Payable- 10/1/2025     National Funds     Ticker     Distribution Change From Prior Distribution   BlackRock Municipal Income Quality Trust*   BYM   $0.055500   - BlackRock Long-Term Municipal Advantage Trust* BTA $0.049500 - BlackRock MuniAssets Fund, Inc.* MUA $0.055500 - BlackRock Municipal Income Trust* BFK $0.050000 - BlackRock Investment Q

    9/2/25 5:26:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    $BTX
    SEC Filings

    View All

    SEC Form N-CSRS filed by BlackRock Technology and Private Equity Term Trust

    N-CSRS - BlackRock Technology & Private Equity Term Trust (0001836057) (Filer)

    9/4/25 4:26:20 PM ET
    $BTX

    SEC Form N-PX filed by BlackRock Technology and Private Equity Term Trust

    N-PX - BlackRock Technology & Private Equity Term Trust (0001836057) (Filer)

    8/28/25 6:58:08 AM ET
    $BTX

    Amendment: SEC Form SCHEDULE 13D/A filed by BlackRock Technology and Private Equity Term Trust

    SCHEDULE 13D/A - BlackRock Technology & Private Equity Term Trust (0001836057) (Subject)

    7/11/25 5:12:41 PM ET
    $BTX

    $BTX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Saba Capital Management, L.P. disposed of $454,458,709 worth of shares (60,675,395 units at $7.49) (SEC Form 4)

    4 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)

    7/10/25 3:48:00 PM ET
    $BTX

    New insider Minar Stephen Thomas claimed ownership of 1,967 shares (SEC Form 3)

    3 - BlackRock Technology & Private Equity Term Trust (0001836057) (Issuer)

    5/16/25 4:24:38 PM ET
    $BTX

    SEC Form 3 filed by new insider Cicala Peter

    3 - Eterna Therapeutics Inc. (0000748592) (Issuer)

    2/16/24 5:30:35 PM ET
    $BTX

    $BTX
    Leadership Updates

    Live Leadership Updates

    View All

    Brooklyn ImmunoTherapeutics Announces Changes to Executive Management: Matt Angel, Ph.D. Appointed Interim Chief Executive Officer and President, Andrew Jackson Appointed Chief Financial Officer Postpones 2022 Annual Meeting

    SAN DIEGO, May 31, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX) ("Brooklyn" or the "Company"), a biopharmaceutical company focused on exploring the role that cytokine, gene editing, and cell therapy can have on the immune system for treating patients with cancer, blood disorders, and monogenic diseases, today announced the appointment of Matt Angel, Ph.D., Co-Founder, Chairman, and CEO of Factor Bioscience Inc., as Interim Chief Executive Officer and President. He will replace Howard J. Federoff, M.D., Ph.D., Chief Executive Officer and President, who departs to focus on building a new venture. The Company also announces the appointment of Andrew Jackson as Chief

    5/31/22 7:30:00 AM ET
    $BTX

    Amarin Announces Appointment of New Directors and Board Leadership Changes

    Erin Enright and Alfonso "Chito" Zulueta Appointed to Board of Directors New Board Members Bring Skills and Experience Aligned with the Company's Strategy Per Wold-Olsen Named Chairman of the Board David Stack and Joe Zakrzewski to Retire from the Board Actions Reflect Company and Board's Commitment to Ongoing Refreshment and Enhancement DUBLIN, Ireland and BRIDGEWATER, N.J., May 19, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced a series of appointments and leadership changes to its Board of Directors, including: Appointment of Erin Enright and Alfonso "Chito" Zulueta to the Board, effective immediately. Ms. Enright and Mr. Zulueta will sta

    5/19/22 8:23:13 AM ET
    $AMRN
    $BTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Brooklyn ImmunoTherapeutics Welcomes Erin S. Enright and Heather B. Redman to Its Board of Directors

    NEW YORK, Jan. 20, 2022 (GLOBE NEWSWIRE) -- Brooklyn ImmunoTherapeutics, Inc. (NASDAQ:BTX) ("Brooklyn"), a biopharmaceutical company focused on exploring the role that cytokine and gene editing/cell therapy can have in treating patients with cancer, blood disorders, and monogenic diseases, today announces the appointment of two new members of the Company's Board of Directors. Erin S. Enright has served on multiple Boards of Directors, including within the medical and life sciences arenas, such as Keystone Dental (serving as Audit Committee Chair), Medical Facilities Corporation (serving as Audit and Investment Committee Chair), and Dynatronics Corporation (serving on the Audit, Compensati

    1/20/22 7:30:00 AM ET
    $BTX

    $BTX
    Financials

    Live finance-specific insights

    View All

    Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

    Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below. Municipal Funds: Declaration- 9/2/2025 Ex-Date- 9/15/2025 Record- 9/15/2025 Payable- 10/1/2025     National Funds     Ticker     Distribution Change From Prior Distribution   BlackRock Municipal Income Quality Trust*   BYM   $0.055500   - BlackRock Long-Term Municipal Advantage Trust* BTA $0.049500 - BlackRock MuniAssets Fund, Inc.* MUA $0.055500 - BlackRock Municipal Income Trust* BFK $0.050000 - BlackRock Investment Q

    9/2/25 5:26:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions

    Today, BlackRock Resources & Commodities Strategy Trust (NYSE:BCX), BlackRock Enhanced Equity Dividend Trust (NYSE:BDJ), BlackRock Energy and Resources Trust (NYSE:BGR), BlackRock Enhanced International Dividend Trust (NYSE:BGY), BlackRock Health Sciences Trust (NYSE:BME), BlackRock Health Sciences Term Trust (NYSE:BMEZ), BlackRock Enhanced Global Dividend Trust (NYSE:BOE), BlackRock Utilities, Infrastructure & Power Opportunities Trust (NYSE:BUI), BlackRock Enhanced Large Cap Core Fund, Inc. (NYSE:CII), BlackRock Science and Technology Trust (NYSE:BST), BlackRock Science and Technology Term Trust (NYSE:BSTZ), BlackRock Technology and Private Equity Term Trust (NYSE:BTX), BlackRock Capital

    8/29/25 4:30:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

    Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below. Municipal Funds: Declaration- 8/1/2025 Ex-Date- 8/15/2025 Record- 8/15/2025 Payable- 9/2/2025 National Funds Ticker Distribution Change From Prior Distribution BlackRock Municipal Income Quality Trust* BYM $0.055500 - BlackRock Long-Term Municipal Advantage Trust* BTA $0.049500 - BlackRock MuniAssets Fund, Inc.* MUA $0.055500 - BlackRock Municipal Income Trust* BFK $0.050000 - BlackRock Investment Quality Municipal Trust, Inc.* BKN $0.057000

    8/1/25 4:30:00 PM ET
    $BBN
    $BCAT
    $BCX
    Finance Companies
    Finance
    Finance/Investors Services
    Trusts Except Educational Religious and Charitable

    $BTX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Brooklyn ImmunoTherapeutics Inc. (Amendment)

    SC 13G/A - Eterna Therapeutics Inc. (0000748592) (Subject)

    1/31/24 7:05:56 AM ET
    $BTX

    SEC Form SC 13G/A filed by Brooklyn ImmunoTherapeutics Inc. (Amendment)

    SC 13G/A - Eterna Therapeutics Inc. (0000748592) (Subject)

    1/19/24 10:31:54 AM ET
    $BTX

    SEC Form SC 13D/A filed by Brooklyn ImmunoTherapeutics Inc. (Amendment)

    SC 13D/A - Eterna Therapeutics Inc. (0000748592) (Subject)

    12/22/23 12:05:20 PM ET
    $BTX